Table 1 Associations of the NLR, PLR and MLR with other clinicopathological variables
Clinicopathologic Characteristics | Total | Low NLR | High NLR | P | Low PLR | High PLR | P | Low MLR | High MLR | P |
|---|---|---|---|---|---|---|---|---|---|---|
(n = 1111), No (%) | (n = 612, 55.1%), No (%) | (n = 499, 44.9%), No (%) |  | (n = 647, 58.2%), No (%) | (n = 464, 41.8%), No (%) |  | (n = 687, 61.8%), No (%) | (n = 424, 38.2%), No (%) |  | |
Age, y | ||||||||||
 <55 | 467 (42.0) | 235 (38.4) | 232 (46.5) | 0.003 | 223 (34.5) | 244 (52.6) | <0.001 | 276 (40.2) | 191 (45.0) | 0.019 |
 55–64 | 488 (43.9) | 298 (48.7) | 190 (38.1) |  | 326 (50.4) | 162 (34.9) |  | 324 (47.2) | 164 (38.7) |  |
 65–74 | 131 (11.8) | 69 (11.3) | 62 (12.4) |  | 85 (13.1) | 46 (9.9) |  | 76 (11.1) | 55 (13.0) |  |
  ≥ 75 | 25 (2.3) | 10 (1.6) | 15 (3.0) |  | 13 (2.0) | 12 (2.6) |  | 11 (1.6) | 14 (3.3) |  |
Stage | ||||||||||
 I | 926 (83.3) | 523 (85.5) | 403 (80.8) | 0.027 | 562 (86.9) | 364 (78.4) | <0.001 | 592 (86.2) | 334 (78.8) | 0.003 |
 II | 82 (7.4) | 43 (7.0) | 39 (7.8) |  | 39 (6.0) | 43 (9.3) |  | 44 (6.4) | 38 (9.0) |  |
 III | 86 (7.7) | 42 (6.9) | 44 (8.8) |  | 43 (6.6) | 43 (9.3) |  | 46 (6.7) | 40 (9.4) |  |
 IV | 17 (1.5) | 4 (0.7) | 13 (2.6) |  | 3 (0.5) | 14 (3.0) |  | 5 (0.7) | 12 (2.8) |  |
Grade | ||||||||||
 1 | 510 (45.9) | 285 (46.6) | 225 (45.1) | 0.19 | 298 (46.1) | 212 (45.7) | <0.001 | 314 (45.7) | 196 (46.2) | 0.043 |
 2 | 378 (34.0) | 216 (35.3) | 162 (32.5) |  | 246 (38.0) | 132 (28.4) |  | 249 (36.2) | 129 (30.4) |  |
 3 | 223 (20.1) | 111 (18.1) | 112 (22.4) |  | 103 (15.9) | 120 (25.9) |  | 124 (18.1) | 99 (23.4) |  |
BMI, kg/m2 | ||||||||||
 <25 | 467 (42.0) | 241 (39.4) | 226 (45.3) | 0.096 | 258 (39.9) | 209 (45.0) | 0.192 | 284 (41.3) | 183 (43.2) | 0.406 |
 25–30 | 547 (49.2) | 319 (52.1) | 228 (45.7) |  | 333 (51.5) | 214 (33.1) |  | 337 (49.1) | 210 (49.5) |  |
  ≥ 30 | 97 (8.7) | 52 (8.5) | 45 (9.0) |  | 56 (8.7) | 41 (8.8) |  | 66 (9.6) | 31 (7.3) |  |
Diabetes | ||||||||||
 Absent | 918 (82.6) | 498 (81.4) | 420 (84.2) | 0.221 | 526 (81.3) | 392 (84.5) | 0.167 | 560 (81.5) | 358 (84.4) | 0.212 |
 Present | 193 (17.4) | 114 (18.6) | 79 (15.8) |  | 121 (18.7) | 72 (15.5) |  | 127 (18.5) | 66 (15.6) |  |
Lymphovascular space invasion | ||||||||||
 Absent | 1081 (97.3) | 597 (97.5) | 484 (97.0) | 0.57 | 631 (97.5) | 450 (97.0) | 0.581 | 668 (97.2) | 413 (97.4) | 0.864 |
 Present | 30 (2.7) | 15 (2.5) | 15 (3.0) |  | 16 (2.5) | 14 (3.0) |  | 19 (2.8) | 11 (2.6) |  |
Histopathological subtype | ||||||||||
 Endometrioid | 1021 (91.9) | 572 (93.5) | 449 (90.0) | 0.297 | 610 (94.3) | 411 (88.6) | 0.025 | 1021 (91.9) | 384 (90.6) | 0.427 |
 Stromal sarcoma | 4 (0.4) | 1 (0.2) | 3 (0.6) |  | 2 (0.3) | 2 (0.4) |  | 4 (0.4) | 1 (0.2) |  |
 Clear cell | 6 (0.5) | 2 (0.3) | 4 (0.8) |  | 2 (0.3) | 4 (0.9) |  | 6 (0.5) | 4 (0.9) |  |
 Serous | 25 (2.3) | 10 (1.6) | 15 (3.0) |  | 12 (1.9) | 13 (2.8) |  | 25 (2.3) | 13 (3.1) |  |
 Mixed | 25 (2.3) | 12 (2.0) | 13 (2.6) |  | 10 (1.5) | 15 (3.2) |  | 25 (2.3) | 9 (2.1) |  |
 Carcinosarcoma | 30 (2.7) | 15 (2.5) | 15 (3.0) |  | 11 (1.7) | 19 (4.1) |  | 30 (2.7) | 13 (3.1) |  |